Skip to main content
David Robbins, MD, Endocrinology, Kansas City, KS

DavidRobbinsMD

Endocrinology Kansas City, KS

Diabetes, Lipid Metabolism, Thyroid

Prof of medicine, director KU Diabetes institute.

Dr. Robbins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Robbins' full profile

Already have an account?

  • Office

    3901 Rainbow Blvd
    Stop 2024
    Kansas City, KS 66160
    Phone+1 913-588-6022
    Fax+1 913-535-2101

Education & Training

  • University of Chicago Medical Center
    University of Chicago Medical Center1978 - 1980
  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1976 - 1978
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 1974 - 1976
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1974

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2005 - 2025
  • MO State Medical License
    MO State Medical License 2018 - 2025
  • DC State Medical License
    DC State Medical License 1991 - 2006
  • MD State Medical License
    MD State Medical License 1993 - 2003
  • VT State Medical License
    VT State Medical License 1975 - 1996
  • IL State Medical License
    IL State Medical License 1978 - 1982
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Awardee Kansas University school of medicine Rainbow Award best teacher, 2008
  • Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Type 1 Diabetes: Why Cases Are Expected to Double Worldwide by 2040
    Type 1 Diabetes: Why Cases Are Expected to Double Worldwide by 2040October 5th, 2022
  • Is the Newest Diabetes Treatment Always the Best?
    Is the Newest Diabetes Treatment Always the Best?August 21st, 2017
  • Big News! FDA Votes to Show Heart Benefits on GLP-1 Agonist Victoza's Label
    Big News! FDA Votes to Show Heart Benefits on GLP-1 Agonist Victoza's LabelJune 21st, 2017